CClinicalTrials.gg
Sign In
Status unknownNCT01238744MUCISATUpdated Nov 11, 2010

Flaxseed Mucilage and Satiety

An interventional study of Flaxseed drink and Flaxseed drink in Appetite, sponsored by University of Copenhagen. Status unknown. Open to participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2010-11-11.

Sponsored by University of Copenhagen · Not applicable, Interventional, and Prevention

The sponsor has not verified this record recently (last verified Aug 2010), so the status shown — last known as Active, not recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
45
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
All
01

Study summary

The effect of a single dose of flaxseed mucilage incorporated into either drinks or tablets will be tested in term of their effect on appetite sensation measured using visual analogue scales over 120 minutes and ad libitum energy intake hereafter in two studies.

Read the detailed description

Study I:

Control drink vs. Flaxseed drink consumed and appetite sensation registered over 120 minutes. Hereafter energy intake was measured.

Study II:

Flaxseed drink vs. Flaxseed tablets+control drink consumed and appetite sensation registered over 120 minutes. Hereafter energy intake was measured.

02

Conditions studied

  • Appetite
03

In context

Lead sponsor

University of Copenhagen is the lead sponsor of 450 studies on the registry; 61 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • healthy adults
  • 18-40 years
  • BMI 19-28

Exclusion criteria

Exclusion Criteria:

  • smoking
  • pregnancy or lactation
  • excessive exercise
  • medication (oral contraceptives the only exception)
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
45 participants (actual)

Study arms

  • Placebo comparator
    Study I: control drink

    Dietary Supplement: Control drink

  • Experimental
    Study I: flaxseed drink

    Dietary Supplement: Flaxseed drink

  • Active comparator
    Study II: flaxseed drink

    Dietary Supplement: Flaxseed drink

  • Experimental
    Study II: flaxseed tablets

    Dietary Supplement: Flaxseed tablet

Interventions

  • Dietary supplementFlaxseed drink

    Drink containing flaxseed mucilage

  • Dietary supplementFlaxseed drink

    Drink containing flaxseed mucilage

  • Dietary supplementFlaxseed tablet

    Tablets containing flaxseed mucilage consumed with a control drink

  • Dietary supplementControl drink

    Control drink

06

What researchers measure

Primary outcomes

  1. Appetite sensation

    Appetite sensation measured by visual analogue scales

    Time frame: 120 minutes

Secondary outcomes

  1. Energy intake

    Ad libitum energy intake at the next meal

    Time frame: 120 minutes

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 11, 2010, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01238744
Lead sponsor
University of Copenhagen
First posted
Nov 11, 2010
Start date
Aug 2009
Primary completion
Aug 2010
Completion
Dec 2010 (estimated)
Last update
Nov 11, 2010

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2010. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

University of Copenhagen

Start the discussion